Full Text
The Full Text of this article is available as a PDF (104.5 KB).
Figure 1: .
A schema within which to consider aspects of a treatment. Information on many of these can be obtained within the context of a large scale trial.
Figure 2: .
Net benefit is a composite of absolute benefit (which will often vary according to baseline level of risk) and harm (which is often independent of the level of risk).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cohen-Solal A., Desnos M., Delahaye F., Emeriau J. P., Hanania G. A national survey of heart failure in French hospitals. The Myocardiopathy and Heart Failure Working Group of the French Society of Cardiology, the National College of General Hospital Cardiologists and the French Geriatrics Society. Eur Heart J. 2000 May;21(9):763–769. doi: 10.1053/euhj.1999.1762. [DOI] [PubMed] [Google Scholar]
- Lauer M. S., Blackstone E. H., Young J. B., Topol E. J. Cause of death in clinical research: time for a reassessment? J Am Coll Cardiol. 1999 Sep;34(3):618–620. doi: 10.1016/s0735-1097(99)00250-8. [DOI] [PubMed] [Google Scholar]
- McAlister F. A., Laupacis A., Wells G. A., Sackett D. L. Users' Guides to the Medical Literature: XIX. Applying clinical trial results B. Guidelines for determining whether a drug is exerting (more than) a class effect. JAMA. 1999 Oct 13;282(14):1371–1377. doi: 10.1001/jama.282.14.1371. [DOI] [PubMed] [Google Scholar]
- Pitt B., Poole-Wilson P. A., Segal R., Martinez F. A., Dickstein K., Camm A. J., Konstam M. A., Riegger G., Klinger G. H., Neaton J. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II. Lancet. 2000 May 6;355(9215):1582–1587. doi: 10.1016/s0140-6736(00)02213-3. [DOI] [PubMed] [Google Scholar]
- Roberts P. R., Betts T. R., Morgan J. M. Cost effectiveness of the implantable cardioverter defibrillator. Eur Heart J. 2000 May;21(9):712–719. doi: 10.1053/euhj.1999.1878. [DOI] [PubMed] [Google Scholar]
- Smeeth L., Haines A., Ebrahim S. Numbers needed to treat derived from meta-analyses--sometimes informative, usually misleading. BMJ. 1999 Jun 5;318(7197):1548–1551. doi: 10.1136/bmj.318.7197.1548. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Steel N. Thresholds for taking antihypertensive drugs in different professional and lay groups: questionnaire survey. BMJ. 2000 May 27;320(7247):1446–1447. doi: 10.1136/bmj.320.7247.1446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Thiemann D. R., Coresh J., Schulman S. P., Gerstenblith G., Oetgen W. J., Powe N. R. Lack of benefit for intravenous thrombolysis in patients with myocardial infarction who are older than 75 years. Circulation. 2000 May 16;101(19):2239–2246. doi: 10.1161/01.cir.101.19.2239. [DOI] [PubMed] [Google Scholar]
- White H. D. Thrombolytic therapy and equivalence trials. J Am Coll Cardiol. 1998 Mar 1;31(3):494–496. doi: 10.1016/s0735-1097(97)00551-2. [DOI] [PubMed] [Google Scholar]
- Wood D., De Backer G., Faergeman O., Graham I., Mancia G., Pyörälä K. Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Atherosclerosis. 1998 Oct;140(2):199–270. doi: 10.1016/s0021-9150(98)90209-x. [DOI] [PubMed] [Google Scholar]
- de Feyter P. J., Nieman K., van Ooijen P., Oudkerk M. Non-invasive coronary artery imaging with electron beam computed tomography and magnetic resonance imaging. Heart. 2000 Oct;84(4):442–448. doi: 10.1136/heart.84.4.442. [DOI] [PMC free article] [PubMed] [Google Scholar]